1. Adam, C. P., & Brantner, V. V. (2006). Estimating the cost of new drug development: Is it really $802 million? Health Affairs, 24, 420–428.
2. Angell, M. (2004). The truth about the drug companies. Random House.
3. Bagley, M. A., et al. (2013). International patent law and policy. West Academic Publishing.
4. Benoliel, D., & Salama, B. (2010). Towards an intellectual property bargaining theory: The post-WTO era. University of Pennsylvania Journal of International Law, 32, 265–368.
5. Clift, C. (2010). Why IPR issues were brought to GATT: A historical perspective on the origins of TRIPS. In C. M. Correa (Ed.), Research handbook on the protection of intellectual property under WTO rules: Intellectual property in the WTO (Vol. I). EE.